Stille develops, manufactures and markets superior quality surgical instruments and operating tables. Instruments and specialty tables for cardio/vascular surgery, plastic surgery and urology/gynaecology are prioritized areas. The company has a stable base with a strong brand name and products of superior quality.
Stille is focused on creating advantages for the surgeons. This will be done by developing, manufacturing and marketing products with a design, a characteristics, a quality and a feeling that make it more possible for the surgeon to work in a comfortable, more efficient and secure way. Stille concentrates on specialty markets by specialty instruments and specialty tables which makes it possible to be one of the three biggest actors on the market.
Stille AB (publ) Year-End Report January-December 2008
January 1 – December 31, 2008 • Net sales totaled SEK 96.6 (94.9) million • Operating loss was SEK 1.3 (loss: 4.6) million • Operating margin was -1.4 % (-4.9) • Net loss for the year totaled SEK 1.8 (loss: 6.3) million • Loss per share SEK 0.37 (loss: 1.60)
Fourth quarter 2008 • Net sales totaled SEK 26.7 (27.0) million • Operating profit amounted to SEK 1.1 (loss: 2.5) million • Operating margin was 4.1 % (-9.4) • Net profit was SEK 1.0 (loss: 2.7) million • Loss per share SEK 0.20 (loss: 0.55) • Stille hires new CFO
Stille signs global supplier agreement with GE Healthcare
Stille has signed a global supplier agreement with GE Healthcare regarding Stille’s operating table ImagiQ™. The agreement concerns marketing of ImagiQ™ in the USA and in other markets. GE Healthcare is already a distributor for the ImagiQ™ in the USA.